Allarity Therapeutics shares are trading lower after the company priced its public offering of 2.44 million shares and warrants to purchase up to 2.44 million shares at combined price of $4.50.
Portfolio Pulse from Benzinga Newsdesk
Allarity Therapeutics has priced its public offering of 2.44 million shares and warrants to purchase up to 2.44 million shares at a combined price of $4.50. This has led to a decrease in the company's share price.
July 06, 2023 | 10:14 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allarity Therapeutics' share price is trading lower after the company priced its public offering of 2.44 million shares and warrants at $4.50.
The company's decision to price its public offering of shares and warrants at $4.50 has led to a decrease in its share price. This is because the offering price is often lower than the current trading price, which can lead to a dilution of existing shares. Therefore, this news is highly relevant and important for investors in Allarity Therapeutics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100